|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 January 2018 |
|
Main ID: |
NCT02803528 |
|
Date of registration:
|
14/06/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping
|
|
Scientific title:
|
A Comparative Study of the Performance of Biodentine and Mineral Trioxide Aggregate (MTA) in Direct Pulp Capping of Deeply Carious Teeth. |
|
Date of first enrolment:
|
January 2015 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02803528 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Syrian Arab Republic
| | | | | | | |
|
Contacts
|
|
Name:
|
Souad Abboud, DDS MSc PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Associate Professor of Operative Dentistry, University of Damascus Dental School, Damascus, Syria |
|
|
Name:
|
Mohammad MN Aldakak, DDS MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
PhD Student in Operative Dentistry |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. asymptomatic vital molars (upper or lower)
2. with complete formation of roots
3. Aged 15 to 30 years.
4. Accidental point pulp exposure during the process of removing dental caries.
Exclusion Criteria:
1. If the molar not vital.
2. If the molar is symptomatic.
3. Immature molar.
4. Patient not in age between (15-30 years).
Age minimum:
15 Years
Age maximum:
30 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Patients With Deep Carious Lesions
|
|
Intervention(s)
|
|
Drug: Biodentine
|
|
Drug: MTA
|
|
Primary Outcome(s)
|
|
Success at 24 months following capping
[Time Frame: the success of treatment is assessed at 24 months following the application of the material]
|
|
Success at 6 months following capping
[Time Frame: the success of treatment is assessed at six months following the application of the material]
|
|
Success at 12 months following capping
[Time Frame: the success of treatment is assessed at 12 months following the application of the material]
|
|
Success at 3 months following capping
[Time Frame: the success of treatment is assessed at three months following the application of the material]
|
|
Success at 18 months following capping
[Time Frame: the success of treatment is assessed at 18 months following the application of the material]
|
|
Success at 9 months following capping
[Time Frame: the success of treatment is assessed at 9 months following the application of the material]
|
|
Secondary ID(s)
|
|
UDDS-OperDent-01-2016
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|